New Nordic Healthbrands AB (OSTO:NNH) Notes Receivable: kr0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:NNH New Nordic Healthbrands AB OSTO:NNH
59 GF Score
Price kr12.10
GF Value kr19.98
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is New Nordic Healthbrands AB Notes Receivable?

New Nordic Healthbrands AB OSTO:NNH -0.82% 59 Notes Receivable is kr0.0 Mil as of Mar. 2026. GuruFocus rates OSTO:NNH with a GF Score™ of 59/100 and a GF Value™ of kr19.98 (Significantly Undervalued). The stock has 4 warning signs investors should review.

New Nordic Healthbrands AB's Notes Receivable for the quarter that ended in Mar. 2026 was kr0.0 Mil.

New Nordic Healthbrands AB Notes Receivable Related Terms

New Nordic Healthbrands AB Notes Receivable Historical Data

* Premium members only.

The historical data trend for New Nordic Healthbrands AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Nordic Healthbrands AB Notes Receivable Chart

New Nordic Healthbrands AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

New Nordic Healthbrands AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:NNH
59GF Score
New Nordic Healthbrands AB OSTO:NNH
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

New Nordic Healthbrands AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of kr0.0 Mil mean?
New Nordic Healthbrands AB (OSTO:NNH) has a Notes Receivable of kr0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on New Nordic Healthbrands AB and its competitors.
Is New Nordic Healthbrands AB's Notes Receivable too high?
New Nordic Healthbrands AB's current Notes Receivable is kr0.0 Mil. Overall, New Nordic Healthbrands AB has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does New Nordic Healthbrands AB's Notes Receivable compare to KHC and GIS?
New Nordic Healthbrands AB's Notes Receivable of kr0.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Consumer Packaged Goods company?
A good Notes Receivable depends on the Consumer Packaged Goods industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on New Nordic Healthbrands AB and its competitors. New Nordic Healthbrands AB's current Notes Receivable is kr0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Nordic Healthbrands AB stock overvalued right now?
Based on GuruFocus' analysis, New Nordic Healthbrands AB (OSTO:NNH) is currently considered Significantly Undervalued. The stock's GF Value™ is kr19.98, compared to a current price of kr12.10 — trading 39.4% below its estimated fair value. The current Notes Receivable is kr0.0 Mil. New Nordic Healthbrands AB's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For New Nordic Healthbrands AB (OSTO:NNH), the current Notes Receivable is kr0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is New Nordic Healthbrands AB (OSTO:NNH) Overvalued in 2026?

Based on GuruFocus' analysis, New Nordic Healthbrands AB stock appears to be undervalued. The current stock price of kr12.10 is trading 39.4% below its estimated GF Value™ of kr19.98. GuruFocus considers New Nordic Healthbrands AB to be Significantly Undervalued.

Key valuation signals for OSTO:NNH:

  • Notes Receivable: kr0.0 Mil
  • GF Value™: kr19.98 vs. price of kr12.10 (39.4% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the OSTO:NNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

New Nordic Healthbrands AB Business Description

Address Sodra Forstadsgatan 3, Malmo, SWE, 211 43
New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.
59GF Score

Get the complete analysis for OSTO:NNH

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.10
Price
kr19.98
GF Value